Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Olson

Concepts (319)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vitreous Body
14
2020
110
2.850
 Why?
Ophthalmologic Surgical Procedures
5
2017
58
2.100
 Why?
Angiogenesis Inhibitors
11
2022
229
1.920
 Why?
Retina
11
2016
298
1.650
 Why?
Eye Foreign Bodies
5
2016
25
1.530
 Why?
Alloys
4
2013
35
1.530
 Why?
Glaucoma
4
2017
237
1.520
 Why?
Macular Edema
4
2022
43
1.490
 Why?
Retinal Detachment
6
2019
63
1.460
 Why?
Vitrectomy
7
2019
70
1.410
 Why?
Diabetic Retinopathy
6
2019
189
1.370
 Why?
Glaucoma Drainage Implants
3
2016
46
1.350
 Why?
Retinal Diseases
5
2017
91
1.190
 Why?
Intraocular Pressure
7
2017
307
1.170
 Why?
Nanopores
2
2020
8
1.160
 Why?
Intravitreal Injections
7
2022
56
1.130
 Why?
Membranes, Artificial
2
2020
72
1.130
 Why?
Nanotechnology
2
2020
125
1.060
 Why?
Suction
3
2015
34
0.980
 Why?
Sutures
3
2015
58
0.930
 Why?
Anterior Eye Segment
2
2017
9
0.910
 Why?
Choroidal Neovascularization
4
2011
56
0.910
 Why?
Swine
10
2017
775
0.900
 Why?
Suture Techniques
3
2015
122
0.890
 Why?
Equipment Design
6
2017
522
0.870
 Why?
Lens Implantation, Intraocular
2
2015
59
0.840
 Why?
Retinitis
1
2022
20
0.770
 Why?
Retinal Vasculitis
1
2022
10
0.770
 Why?
Aneurysm
1
2022
31
0.760
 Why?
Vitreoretinopathy, Proliferative
2
2019
14
0.710
 Why?
Vascular Endothelial Growth Factor A
6
2020
545
0.690
 Why?
Antibodies, Monoclonal
6
2020
1430
0.690
 Why?
Durapatite
1
2020
37
0.670
 Why?
Retinal Vessels
2
2015
69
0.670
 Why?
Cytomegalovirus Retinitis
2
2013
21
0.650
 Why?
Isoxazoles
2
2013
54
0.650
 Why?
Eye Injuries, Penetrating
3
2016
19
0.640
 Why?
Scleral Buckling
3
2012
18
0.640
 Why?
Endophthalmitis
2
2017
29
0.640
 Why?
Complement System Proteins
2
2020
327
0.640
 Why?
Immunosuppressive Agents
3
2013
894
0.630
 Why?
Disease Models, Animal
8
2020
4295
0.620
 Why?
Stents
2
2013
527
0.590
 Why?
Fluorocarbons
2
2012
117
0.560
 Why?
Anterior Chamber
1
2017
22
0.540
 Why?
Transducers
1
2017
27
0.540
 Why?
Glucocorticoids
2
2020
596
0.530
 Why?
Strabismus
1
2017
29
0.530
 Why?
Sclera
2
2015
36
0.510
 Why?
Filtering Surgery
1
2016
22
0.510
 Why?
Trabeculectomy
1
2017
72
0.500
 Why?
Surgical Instruments
2
2013
51
0.500
 Why?
Fovea Centralis
2
2006
11
0.490
 Why?
Retinal Perforations
2
2005
16
0.480
 Why?
Drug Resistance, Multiple, Viral
2
2013
10
0.480
 Why?
Ocular Hypertension
1
2016
69
0.480
 Why?
Ophthalmology
2
2013
86
0.480
 Why?
Lenses, Intraocular
1
2015
43
0.470
 Why?
Laser Therapy
1
2017
130
0.470
 Why?
Monitoring, Physiologic
1
2017
283
0.460
 Why?
Lasers
1
2015
130
0.460
 Why?
Device Removal
1
2016
136
0.450
 Why?
Prostheses and Implants
1
2016
143
0.440
 Why?
Tomography, Optical Coherence
7
2015
213
0.440
 Why?
Ischemia
2
2017
409
0.430
 Why?
Antiviral Agents
2
2013
744
0.430
 Why?
Fluorescein Angiography
9
2012
151
0.420
 Why?
Models, Cardiovascular
1
2015
198
0.420
 Why?
Rabbits
3
2020
794
0.420
 Why?
Retinal Degeneration
2
2015
38
0.410
 Why?
Artificial Lens Implant Migration
1
2013
3
0.410
 Why?
Choroid
3
2015
62
0.400
 Why?
Macular Degeneration
6
2015
164
0.400
 Why?
Viscosupplements
1
2012
11
0.400
 Why?
Gravitation
1
2012
18
0.400
 Why?
Animals
18
2020
36951
0.400
 Why?
Silicon
1
2012
16
0.390
 Why?
Silicone Oils
1
2012
28
0.390
 Why?
Pupil Disorders
1
2012
5
0.390
 Why?
Eye Enucleation
1
2012
12
0.390
 Why?
Iris
1
2012
19
0.390
 Why?
Viremia
1
2013
138
0.380
 Why?
Quantum Dots
1
2012
37
0.380
 Why?
Silicone Elastomers
1
2012
7
0.380
 Why?
Uveitis, Posterior
1
2012
12
0.380
 Why?
Prosthesis Implantation
1
2013
153
0.370
 Why?
Surgical Stapling
1
2012
15
0.370
 Why?
Fluocinolone Acetonide
1
2012
19
0.370
 Why?
Vitreous Hemorrhage
2
2015
5
0.370
 Why?
Electric Stimulation Therapy
1
2012
81
0.360
 Why?
Cataract Extraction
1
2013
98
0.360
 Why?
Vascular Endothelial Growth Factors
1
2011
79
0.360
 Why?
Models, Biological
4
2015
1783
0.350
 Why?
Materials Testing
1
2012
356
0.330
 Why?
Cytomegalovirus
2
2013
157
0.330
 Why?
Oxygen
1
2015
938
0.320
 Why?
Humans
47
2022
137782
0.310
 Why?
Anti-Inflammatory Agents
1
2012
496
0.290
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
253
0.280
 Why?
Biocompatible Materials
1
2012
425
0.280
 Why?
Electroretinography
5
2016
48
0.270
 Why?
von Hippel-Lindau Disease
1
2007
12
0.270
 Why?
Injections
5
2012
183
0.260
 Why?
Pigment Epithelium of Eye
2
2006
35
0.260
 Why?
Puerperal Disorders
1
2007
31
0.260
 Why?
Recombinant Fusion Proteins
4
2022
665
0.260
 Why?
Drug Implants
2
2020
82
0.260
 Why?
Uveal Diseases
1
2006
5
0.250
 Why?
Ocular Hypotension
1
2006
10
0.250
 Why?
Fusobacterium Infections
1
2006
7
0.250
 Why?
Pharyngeal Diseases
1
2006
16
0.250
 Why?
Needles
2
2017
59
0.250
 Why?
Epiretinal Membrane
1
2005
8
0.250
 Why?
Ciliary Body
1
2006
39
0.240
 Why?
Antibodies, Monoclonal, Humanized
6
2015
804
0.240
 Why?
Telangiectasis
1
2005
7
0.240
 Why?
Visual Acuity
7
2019
356
0.240
 Why?
Rats, Inbred BN
3
2011
58
0.240
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2022
108
0.230
 Why?
Uveitis
1
2006
137
0.230
 Why?
Dementia
2
2022
259
0.230
 Why?
Female
26
2022
73465
0.220
 Why?
Injections, Intraocular
2
2015
10
0.220
 Why?
Kidney Transplantation
2
2013
709
0.220
 Why?
Polypropylenes
2
2015
13
0.220
 Why?
Middle Aged
17
2019
33554
0.200
 Why?
Optic Atrophy
1
2022
8
0.190
 Why?
Hearing Loss, Central
1
2022
6
0.190
 Why?
Bevacizumab
6
2015
138
0.190
 Why?
Laser Coagulation
3
2012
68
0.190
 Why?
Autoimmune Diseases
1
2006
460
0.190
 Why?
Retinal Vein Occlusion
2
2015
13
0.180
 Why?
Cell Count
2
2012
324
0.180
 Why?
Rats
4
2012
5648
0.180
 Why?
Dialysis
1
2020
20
0.170
 Why?
Leukemia, Megakaryoblastic, Acute
1
2000
10
0.170
 Why?
Orbital Neoplasms
1
2000
24
0.170
 Why?
Adsorption
1
2020
149
0.160
 Why?
Time Factors
4
2017
6834
0.160
 Why?
Follow-Up Studies
5
2015
5136
0.160
 Why?
Male
21
2019
67906
0.150
 Why?
Adult
11
2022
38023
0.150
 Why?
Biomarkers
2
2020
4154
0.150
 Why?
Fluorescein-5-isothiocyanate
2
2009
35
0.150
 Why?
Eye Diseases, Hereditary
1
2018
12
0.150
 Why?
Wet Macular Degeneration
1
2019
56
0.140
 Why?
Miniaturization
2
2015
22
0.140
 Why?
Geographic Atrophy
1
2019
79
0.140
 Why?
Dextrans
2
2009
84
0.140
 Why?
Iris Diseases
1
2017
6
0.140
 Why?
Choroid Diseases
1
2017
10
0.140
 Why?
Glomerulonephritis, Membranoproliferative
1
1997
13
0.140
 Why?
Enzyme-Linked Immunosorbent Assay
1
2019
853
0.130
 Why?
Dark Adaptation
2
2012
13
0.130
 Why?
Antimony
1
2016
5
0.130
 Why?
Hypertension
1
2006
1298
0.130
 Why?
Infliximab
2
2007
111
0.130
 Why?
Dose-Response Relationship, Drug
3
2014
2057
0.130
 Why?
Pressure
1
2017
225
0.130
 Why?
Polymers
1
2020
490
0.130
 Why?
Sclerostomy
1
2015
4
0.120
 Why?
Aged, 80 and over
6
2019
7637
0.120
 Why?
Foreign-Body Migration
1
2016
34
0.120
 Why?
Gyrate Atrophy
1
2015
2
0.120
 Why?
Eye Infections, Bacterial
1
2015
28
0.120
 Why?
Vitreoretinal Surgery
1
2015
5
0.120
 Why?
Treatment Outcome
9
2016
10837
0.120
 Why?
Equipment Failure Analysis
1
2015
132
0.120
 Why?
Vitreous Detachment
1
2015
9
0.120
 Why?
Diagnostic Techniques, Ophthalmological
1
2015
40
0.120
 Why?
Partial Pressure
1
2015
30
0.120
 Why?
Stress, Mechanical
1
2017
485
0.120
 Why?
Hemoglobin SC Disease
1
2015
13
0.120
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1330
0.120
 Why?
Biopsy, Needle
1
2015
189
0.110
 Why?
Prosthesis Failure
1
2016
123
0.110
 Why?
Feedback
1
2015
173
0.110
 Why?
Aged
10
2020
24001
0.110
 Why?
Oculomotor Muscles
1
2014
40
0.110
 Why?
International Normalized Ratio
1
2014
47
0.110
 Why?
Protein Binding
1
2020
2224
0.110
 Why?
Exchange Transfusion, Whole Blood
1
2013
16
0.110
 Why?
Postoperative Care
1
2015
261
0.110
 Why?
Tendons
1
2014
111
0.100
 Why?
Retinal Artery Occlusion
1
2013
9
0.100
 Why?
In Vitro Techniques
1
2015
1092
0.100
 Why?
Down Syndrome
1
2000
497
0.100
 Why?
Warfarin
1
2014
154
0.100
 Why?
Specific Gravity
1
2012
11
0.100
 Why?
Transducers, Pressure
1
2012
12
0.100
 Why?
Diabetes Mellitus, Type 2
2
2012
2534
0.100
 Why?
Adaptation, Ocular
1
2012
4
0.100
 Why?
Erythrocyte Transfusion
1
2015
194
0.100
 Why?
Rats, Mutant Strains
1
2012
25
0.100
 Why?
Metabolomics
1
2018
678
0.100
 Why?
Minerals
1
2012
42
0.100
 Why?
Viscosity
1
2012
92
0.100
 Why?
Pupil
1
2012
18
0.100
 Why?
Research Design
1
2019
1139
0.100
 Why?
Acetates
1
2012
99
0.100
 Why?
Antineoplastic Agents
2
2020
2129
0.100
 Why?
Corneal Endothelial Cell Loss
1
2012
2
0.090
 Why?
Sodium Chloride
1
2012
142
0.090
 Why?
Endothelium, Corneal
1
2012
16
0.090
 Why?
Retinal Neovascularization
1
2012
25
0.090
 Why?
Electrodes, Implanted
1
2012
109
0.090
 Why?
Swine, Miniature
1
2012
82
0.090
 Why?
Microsurgery
1
2012
75
0.090
 Why?
Tumor Necrosis Factor-alpha
2
2007
1242
0.090
 Why?
Drug Combinations
1
2012
343
0.090
 Why?
Bruch Membrane
1
2011
6
0.090
 Why?
Gold
1
2012
118
0.090
 Why?
Retinal Ganglion Cells
1
2012
110
0.090
 Why?
Polyglycolic Acid
1
2011
43
0.090
 Why?
Adolescent
4
2019
21574
0.090
 Why?
Administration, Oral
1
2013
816
0.090
 Why?
Registries
1
2019
2041
0.090
 Why?
Drug Compounding
1
2011
101
0.090
 Why?
Dissection
1
2011
52
0.080
 Why?
Delayed-Action Preparations
1
2011
181
0.080
 Why?
Computer Simulation
1
2015
982
0.080
 Why?
Models, Animal
1
2012
384
0.080
 Why?
Atrial Fibrillation
1
2014
390
0.080
 Why?
Anemia, Sickle Cell
1
2013
270
0.080
 Why?
Lactic Acid
1
2011
305
0.080
 Why?
Retrospective Studies
8
2015
15682
0.080
 Why?
Cell Survival
1
2012
1120
0.080
 Why?
Bacteria
1
2015
858
0.070
 Why?
Scotoma
1
2008
5
0.070
 Why?
Proliferating Cell Nuclear Antigen
1
2007
53
0.070
 Why?
Optic Neuropathy, Ischemic
1
2007
30
0.070
 Why?
Papilledema
1
2007
39
0.070
 Why?
Severity of Illness Index
2
2014
2836
0.070
 Why?
Visual Fields
3
2007
90
0.060
 Why?
RNA, Catalytic
1
2007
187
0.060
 Why?
Pilot Projects
1
2012
1713
0.060
 Why?
Retinitis Pigmentosa
1
2006
20
0.060
 Why?
Glycogen Storage Disease Type IIb
1
2006
25
0.060
 Why?
Triamcinolone Acetonide
1
2006
28
0.060
 Why?
Fusobacterium necrophorum
1
2006
2
0.060
 Why?
Vision, Low
3
2013
16
0.060
 Why?
Indocyanine Green
1
2005
24
0.060
 Why?
Polyethylene Glycols
1
2011
641
0.060
 Why?
Myopia
1
2006
47
0.060
 Why?
Eye Injuries
1
2006
45
0.060
 Why?
Coloring Agents
1
2005
87
0.060
 Why?
Infusions, Intravenous
1
2006
413
0.060
 Why?
Staining and Labeling
1
2005
151
0.060
 Why?
Young Adult
2
2019
13240
0.060
 Why?
Syndrome
1
2006
358
0.060
 Why?
Cataract
1
2006
213
0.050
 Why?
Multivariate Analysis
2
2019
1509
0.050
 Why?
Diagnosis, Differential
1
2007
1483
0.050
 Why?
Ranibizumab
2
2013
20
0.050
 Why?
Blindness
2
2013
38
0.050
 Why?
Keratitis
1
2000
15
0.040
 Why?
Exophthalmos
1
2000
18
0.040
 Why?
Postoperative Complications
1
2012
2659
0.040
 Why?
Chronic Disease
1
2006
1794
0.040
 Why?
Immunophenotyping
1
2000
318
0.040
 Why?
Xanthine
1
2018
7
0.040
 Why?
Tomography, X-Ray Computed
2
2016
2697
0.040
 Why?
Combined Modality Therapy
2
2013
1236
0.040
 Why?
Electrooculography
1
1997
12
0.030
 Why?
Visual Field Tests
1
1997
16
0.030
 Why?
Color Vision Defects
1
1997
8
0.030
 Why?
Fundus Oculi
1
1997
65
0.030
 Why?
Purines
1
2018
176
0.030
 Why?
Cohort Studies
2
2019
5750
0.030
 Why?
Odds Ratio
1
2019
1070
0.030
 Why?
Photic Stimulation
1
1997
241
0.030
 Why?
Vision Disorders
1
1997
142
0.030
 Why?
Child
2
2015
21989
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Endotamponade
1
2015
3
0.030
 Why?
Colony Count, Microbial
1
2015
120
0.030
 Why?
Myopia, Degenerative
1
2015
4
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
32
0.030
 Why?
Metabolome
1
2018
350
0.030
 Why?
Photography
1
2015
96
0.030
 Why?
Mass Spectrometry
1
2018
739
0.030
 Why?
Conjunctiva
1
2014
51
0.030
 Why?
Atrophy
1
2015
184
0.030
 Why?
Biometry
1
2014
70
0.030
 Why?
Disease Progression
2
2015
2760
0.030
 Why?
Pregnancy
1
2007
6771
0.030
 Why?
Glucose
1
2018
1020
0.020
 Why?
Fatty Acids, Omega-3
1
2014
140
0.020
 Why?
Risk Factors
2
2019
10407
0.020
 Why?
Retreatment
1
2012
72
0.020
 Why?
Kaplan-Meier Estimate
1
2014
889
0.020
 Why?
Risk Assessment
2
2014
3461
0.020
 Why?
Oxidative Stress
1
2018
1317
0.020
 Why?
Survival Analysis
1
2014
1325
0.020
 Why?
Proportional Hazards Models
1
2014
1266
0.020
 Why?
Global Health
1
2014
386
0.020
 Why?
Health Care Costs
1
2014
398
0.020
 Why?
Phenotype
1
2019
3196
0.020
 Why?
Antioxidants
1
2014
585
0.020
 Why?
Clinical Trials, Phase II as Topic
1
2009
76
0.020
 Why?
Clinical Trials, Phase I as Topic
1
2009
50
0.020
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
445
0.020
 Why?
Anticoagulants
1
2014
664
0.020
 Why?
Comorbidity
1
2014
1623
0.020
 Why?
Colorado
1
2019
4576
0.020
 Why?
Retinal Artery
1
2007
17
0.020
 Why?
Prospective Studies
2
2012
7623
0.020
 Why?
Cerebral Angiography
1
2007
109
0.020
 Why?
Lysosomal-Associated Membrane Protein 2
1
2006
30
0.020
 Why?
Frameshift Mutation
1
2006
32
0.020
 Why?
Infant
1
2000
9482
0.020
 Why?
Secondary Prevention
1
2007
234
0.020
 Why?
Prognosis
1
2014
4039
0.020
 Why?
Anti-Bacterial Agents
1
2015
1809
0.010
 Why?
Adrenal Cortex Hormones
1
2008
565
0.010
 Why?
Double-Blind Method
1
2007
1997
0.010
 Why?
RNA, Messenger
1
2007
2834
0.010
 Why?
Aging
1
2008
1865
0.010
 Why?
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (319) concept(s)
_
Co-Authors Expand Description
See all (24) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)